Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 2/2019

01-04-2019 | Original Article

Impact of low tissue backscattering by optical coherence tomography on endothelial function after drug-eluting stent implantation

Authors: Hiroto Tamaru, Kenichi Fujii, Tsuyoshi Nakata, Masashi Fukunaga, Takahiro Imanaka, Kenji Kawai, Kojiro Miki, Tetsuo Horimatsu, Machiko Nishimura, Ten Saita, Akinori Sumiyoshi, Masahiko Shibuya, Yoshiro Naito, Tohru Masuyama, Masaharu Ishihara

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2019

Login to get access

Abstract

This study evaluated the impact of optical coherence tomography (OCT)-derived low-backscattered tissue on mid-term coronary endothelial function after drug-eluting stent (DES) implantation. Although OCT enables detailed in vivo evaluation of neointimal tissue characterization after DES implantation, its association with physiological vascular healing response is unclear. Thirty-three stable angina pectoris patients underwent OCT examination and endothelial function testing with intracoronary infusion of incremental doses of acetylcholine 8-month after DES implantation in a single lesion of the left anterior descending artery. Neointimal tissue was classified into two patterns based on the predominant OCT light backscatter: high backscatter and low backscatter. Although the presence of uncovered or malapposed stent strut was not associated with the degree of vasoconstriction, the degree of vasoconstriction was significantly greater in the DES with low-backscattered neointima than in the DES without low-backscattered neointima (− 32.1 ± 25.7 vs. − 4.1 ± 20.1%, p = 0.003). Moreover, there was an inverse linear relationship between low backscatter tissue index and degree of vasoconstriction after acetylcholine infusion (r = 0.50 and p = 0.003). The endothelium-dependent vasomotor response after 8-month of DES was impaired in patients with low neointimal tissue backscatter on OCT imaging. OCT assessment of low-backscattered tissue may be used as surrogate markers for impairment of endothelial function after DES.
Literature
1.
go back to reference Iwasaki M, Otake H, Shinke T, Nakagawa M, Hariki H, Osue T, et al. Vascular responses in patients with and without diabetes mellitus after everolimus-eluting stent implantation. Circ J. 2014;78:2188–96.CrossRefPubMed Iwasaki M, Otake H, Shinke T, Nakagawa M, Hariki H, Osue T, et al. Vascular responses in patients with and without diabetes mellitus after everolimus-eluting stent implantation. Circ J. 2014;78:2188–96.CrossRefPubMed
2.
go back to reference Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J. 2007;28:961–7.CrossRefPubMed Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J. 2007;28:961–7.CrossRefPubMed
3.
go back to reference Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J. 2009;158:284–93.CrossRefPubMed Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J. 2009;158:284–93.CrossRefPubMed
4.
go back to reference Tada T, Kadota K, Hosogi S, Miyake K, Amano H, Nakamura M, et al. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty. Eur Heart J Cardiovasc Imaging. 2014;15:307–15.CrossRefPubMed Tada T, Kadota K, Hosogi S, Miyake K, Amano H, Nakamura M, et al. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty. Eur Heart J Cardiovasc Imaging. 2014;15:307–15.CrossRefPubMed
5.
go back to reference Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol. 2012;110:933–9.CrossRefPubMed Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol. 2012;110:933–9.CrossRefPubMed
6.
go back to reference Minami Y, Kaneda H, Inoue M, Ikutomi M, Morita T, Nakajima T. Endothelial dysfunction following drug-eluting stent implantation: a systematic review of the literature. Int J Cardiol. 2013;165:222–8.CrossRefPubMed Minami Y, Kaneda H, Inoue M, Ikutomi M, Morita T, Nakajima T. Endothelial dysfunction following drug-eluting stent implantation: a systematic review of the literature. Int J Cardiol. 2013;165:222–8.CrossRefPubMed
7.
go back to reference Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, et al. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. JACC Cardiovasc Interv. 2012;5:966–73.CrossRefPubMed Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, et al. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. JACC Cardiovasc Interv. 2012;5:966–73.CrossRefPubMed
8.
go back to reference Fujii K, Kawasaki D, Oka K, Akahori H, Fukunaga M, Sawada H, et al. Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart. 2011;97:977–82.CrossRefPubMed Fujii K, Kawasaki D, Oka K, Akahori H, Fukunaga M, Sawada H, et al. Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart. 2011;97:977–82.CrossRefPubMed
9.
go back to reference Fujii K, Masutani M, Okumura T, Kawasaki D, Akagami T, Ezumi A, et al. Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study. J Am Coll Cardiol. 2008;52:787–8.CrossRefPubMed Fujii K, Masutani M, Okumura T, Kawasaki D, Akagami T, Ezumi A, et al. Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study. J Am Coll Cardiol. 2008;52:787–8.CrossRefPubMed
10.
go back to reference Kim BK, Kim JS, Park J, Ko YG, Choi D, Jang Y, et al. Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents. Yonsei Med J. 2012;53:524–9.CrossRefPubMedPubMedCentral Kim BK, Kim JS, Park J, Ko YG, Choi D, Jang Y, et al. Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents. Yonsei Med J. 2012;53:524–9.CrossRefPubMedPubMedCentral
11.
go back to reference Won H, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, et al. Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography. Int J Cardiovasc Imaging. 2014;30:263–70.CrossRefPubMed Won H, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, et al. Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography. Int J Cardiovasc Imaging. 2014;30:263–70.CrossRefPubMed
12.
go back to reference Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol. 2007;99:1033–8.CrossRefPubMed Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol. 2007;99:1033–8.CrossRefPubMed
13.
go back to reference Kim BK, Kim JS, Oh C, Ko YG, Choi D, Jang Y, et al. Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation. Int J Cardiovasc Imaging. 2012;28:705–14.CrossRefPubMed Kim BK, Kim JS, Oh C, Ko YG, Choi D, Jang Y, et al. Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation. Int J Cardiovasc Imaging. 2012;28:705–14.CrossRefPubMed
14.
go back to reference Vergallo R, Yonetsu T, Uemura S, Park SJ, Lee S, Kato K, et al. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography. Am J Cardiol. 2013;112:1315–21.CrossRefPubMed Vergallo R, Yonetsu T, Uemura S, Park SJ, Lee S, Kato K, et al. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography. Am J Cardiol. 2013;112:1315–21.CrossRefPubMed
15.
go back to reference Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I, et al. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging. 2012;5:660–6.CrossRefPubMed Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I, et al. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging. 2012;5:660–6.CrossRefPubMed
16.
go back to reference Konishi A, Shinke T, Otake H, Takaya T, Nakagawa M, Inoue T, et al. Favorable vessel healing after nobori biolimus A9-eluting stent implantation-6- and 12-month follow-up by optical coherence tomography. Circ J. 2014;78:1882–90.CrossRefPubMed Konishi A, Shinke T, Otake H, Takaya T, Nakagawa M, Inoue T, et al. Favorable vessel healing after nobori biolimus A9-eluting stent implantation-6- and 12-month follow-up by optical coherence tomography. Circ J. 2014;78:1882–90.CrossRefPubMed
17.
go back to reference Lee SY, Shin DH, Mintz GS, Kim JS, Kim BK, Ko YG, et al. Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis. EuroIntervention. 2013;9:945–51.CrossRefPubMed Lee SY, Shin DH, Mintz GS, Kim JS, Kim BK, Ko YG, et al. Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis. EuroIntervention. 2013;9:945–51.CrossRefPubMed
18.
go back to reference Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv. 2010;75:961–3.PubMed Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv. 2010;75:961–3.PubMed
19.
go back to reference Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV, et al. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging. 2012;5:71–82.CrossRefPubMed Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV, et al. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging. 2012;5:71–82.CrossRefPubMed
20.
go back to reference Fujii K, Hao H, Masuyama T. Can optical coherence tomography findings be used as surrogates for vessel healing after drug-eluting stent implantation? Circ J. 2014;78:1826–7.CrossRefPubMed Fujii K, Hao H, Masuyama T. Can optical coherence tomography findings be used as surrogates for vessel healing after drug-eluting stent implantation? Circ J. 2014;78:1826–7.CrossRefPubMed
21.
go back to reference Murata A, Wallace-Bradley D, Tellez A, Alviar C, Aboodi M, Sheehy A, et al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging. 2010;3:76–84.CrossRefPubMed Murata A, Wallace-Bradley D, Tellez A, Alviar C, Aboodi M, Sheehy A, et al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging. 2010;3:76–84.CrossRefPubMed
22.
go back to reference Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:166–70.CrossRefPubMed Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:166–70.CrossRefPubMed
23.
go back to reference Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW, et al. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent. JACC Cardiovasc Interv. 2008;1:65–71.CrossRefPubMed Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW, et al. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent. JACC Cardiovasc Interv. 2008;1:65–71.CrossRefPubMed
24.
go back to reference Nakata T, Fujii K, Fukunaga M, Shibuya M, Kawai K, Kawasaki D, et al. Morphological, functional, and biological vascular healing response 6 months after drug-eluting stent implantation: a randomized comparison of three drug-eluting stents. Catheter Cardiovasc Interv. 2016;88:350–7.CrossRefPubMed Nakata T, Fujii K, Fukunaga M, Shibuya M, Kawai K, Kawasaki D, et al. Morphological, functional, and biological vascular healing response 6 months after drug-eluting stent implantation: a randomized comparison of three drug-eluting stents. Catheter Cardiovasc Interv. 2016;88:350–7.CrossRefPubMed
25.
go back to reference Tanaka N, Terashima M, Rathore S, et al. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis. JACC Cardiovasc Interv. 2010;3:1074–9.CrossRefPubMed Tanaka N, Terashima M, Rathore S, et al. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis. JACC Cardiovasc Interv. 2010;3:1074–9.CrossRefPubMed
26.
go back to reference Nakazawa G, Shinke T, Ijichi T, et al. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model. EuroIntervention. 2014;10:717–23.CrossRefPubMed Nakazawa G, Shinke T, Ijichi T, et al. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model. EuroIntervention. 2014;10:717–23.CrossRefPubMed
27.
go back to reference Hoymans VY, van Dyck CJ, Haine SE, et al. Long-term vascular responses to Resolute® and Xience V® polymer-based drug-eluting stents in a rabbit model of atherosclerosis. J Interv Cardiol. 2014;27:381–90.CrossRefPubMed Hoymans VY, van Dyck CJ, Haine SE, et al. Long-term vascular responses to Resolute® and Xience V® polymer-based drug-eluting stents in a rabbit model of atherosclerosis. J Interv Cardiol. 2014;27:381–90.CrossRefPubMed
28.
go back to reference Hamilos M, Sarma J, Ostojic M, et al. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv. 2008;1:193–200.CrossRefPubMed Hamilos M, Sarma J, Ostojic M, et al. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv. 2008;1:193–200.CrossRefPubMed
29.
go back to reference Sumida A, Gogas BD, Nagai H, et al. A comparison of drug eluting stent biocompatibility between third generation NOBORI biolimus A9-eluting stent and second generation XIENCE V everolimus-eluting stent in a porcine coronary artery model. Cardiovasc Revasc Med. 2015;16:351–7.CrossRefPubMed Sumida A, Gogas BD, Nagai H, et al. A comparison of drug eluting stent biocompatibility between third generation NOBORI biolimus A9-eluting stent and second generation XIENCE V everolimus-eluting stent in a porcine coronary artery model. Cardiovasc Revasc Med. 2015;16:351–7.CrossRefPubMed
Metadata
Title
Impact of low tissue backscattering by optical coherence tomography on endothelial function after drug-eluting stent implantation
Authors
Hiroto Tamaru
Kenichi Fujii
Tsuyoshi Nakata
Masashi Fukunaga
Takahiro Imanaka
Kenji Kawai
Kojiro Miki
Tetsuo Horimatsu
Machiko Nishimura
Ten Saita
Akinori Sumiyoshi
Masahiko Shibuya
Yoshiro Naito
Tohru Masuyama
Masaharu Ishihara
Publication date
01-04-2019
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2019
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-018-0540-y

Other articles of this Issue 2/2019

Cardiovascular Intervention and Therapeutics 2/2019 Go to the issue